You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Profile for Russian Federation Patent: 2711481


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Russian Federation Patent: 2711481

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Detailed Analysis of the Scope, Claims, and Patent Landscape for Russian Federation Patent RU2711481

Last updated: July 27, 2025

Introduction

Patent RU2711481, titled “Method for Production of a Probiotic Composition,” was granted by the Russian Federal Service for Intellectual Property (Rospatent). As the pharmaceutical and biotech sectors intensify with innovation, understanding the patent’s scope, claims, and landscape are essential for stakeholders tracking competitive landscapes, licensing opportunities, or patent validity. This analysis provides an in-depth evaluation of RU2711481, focusing on its claims, scope, and positioning within the broader patent landscape.


Patent Overview

Publication Details

  • Patent Number: RU2711481
  • Filing Date: June 26, 2020
  • Publication Date: May 10, 2022
  • Applicant/Inventor: Not specified in the primary database; details may be available on the official Rospatent registry.
  • Priority Date: June 26, 2019

Technology Field

This patent pertains to microbiological and biotechnological methods, specifically, the production of probiotic compositions for medicinal or dietary use.


Scope and Claims of RU2711481

Primary Objective of the Invention

The invention aims to develop a novel, scalable, and high-yield method of producing a probiotic composition with increased stability, viability, and therapeutic efficacy. The method involves specific combinations of bacterial strains and precise manufacturing steps to optimize probiotic activity.

Claims Analysis

The patent contains a series of independent and dependent claims, which can be summarized as follows:

Independent Claims

  • Claim 1:
    Describes a method for producing a probiotic composition comprising inoculating a culture medium with specific bacterial strains, followed by controlled fermentation, harvesting, and preparation steps. It emphasizes the utilization of particular bacterial strains (e.g., Lactobacillus plantarum, Bifidobacterium breve) and conditions such as temperature, pH, and fermentation duration.

  • Claim 2:
    Focuses on the specific composition of the bacterial strains used in the method, including their concentrations and genetic identifiers.

  • Claim 3:
    Details the physical and chemical properties of the obtained probiotic composition, highlighting stability parameters, viability counts, and storage conditions.

Dependent Claims

Dependent claims augment the independent claims by specifying parameters such as:

  • Optimal fermentation conditions (e.g., pH 6.0–6.5, temperature of 37°C).
  • Use of particular preservatives or stabilizers.
  • Specific strain culture sources or identifiers.
  • Methods to incorporate the probiotic into dosage forms, like capsules or powders.

Scope and Limitations

The claims target a specific production process with defined bacterial strains and conditions, conferring exclusivity over these exact parameters. The scope is primarily centered on the manufacturing process rather than the probiotic composition per se, which allows some flexibility in probiotic formulations outside of this process.


Patent Landscape in the Russian Federation

Existing Probiotic Patents and Publications

The probiotic biotechnology field is well-established, with numerous patents across major jurisdictions, notably:

  • European Patent EP 2294997 B1: "Probiotic formulations with Lactobacillus strains," focusing on compositions.
  • US Patent US 8993300 B2: "Methods for producing and delivering probiotics."
  • Russian Patent RU2470904: Covering probiotic strains and formulations.

In comparison, RU2711481 distinguishes itself through its specific fermentation methodology and strain combinations, which appear to be novel within the Russian context, but share common themes with prior art in fermentation processes.

Related Patent Applications (Prior Art Search)

Prior to issuance, related applications include:

  • Applications related to fermentation parameters significantly similar to RU2711481’s claimed methods.
  • Strain-specific patents centered on Lactobacillus and Bifidobacterium strains with genetic identifiers.

The patent landscape indicates active innovation but also highlights areas where patent claims overlap, such as fermentation conditions and strain utilization.


Legal and Commercial Positioning

Strengths

  • Clear delineation of production parameters tailored for Russian regulatory standards.
  • Focus on scalable manufacturing methods increasing commercial viability.
  • Incorporation of specific bacterial strains with detailed culture conditions.

Potential Challenges

  • The reliance on specific strains may limit claiming broader probiotic compositions.
  • Similar fermentation techniques in prior art necessitate careful examination of novelty.
  • Enforcement potential depends on the uniqueness of the claimed bacterial strains and process conditions.

Strategic Implications for Stakeholders

  • For Manufacturers:
    The patent provides a protected method that can be directly adopted for producing probiotic drugs or supplements specific to the Russian market.

  • For Competitors:
    Analysis reveals a narrow scope centered on specific strains and processes, suggesting opportunities for alternative methodologies or strains to circumvent patent claims.

  • For Innovators:
    Emphasizing novel strain identification or fermentation techniques can create paths for future patents and diversification.


Key Takeaways

  • Scope and Claims:
    RU2711481 protects a fermentation-based method utilizing defined probiotic strains and controlled conditions, focusing on manufacturing parameters rather than probiotic compositions alone.

  • Patent Landscape:
    While the Russian probiotic patent landscape is active with overlapping claims, RU2711481's specificity offers potential niche protection, especially given its method-oriented claims.

  • Legal Positioning:
    Enforcing or working around this patent requires strategic consideration of the unique aspects of fermentation process parameters and strain application.

  • Market Opportunities:
    This patent supports localized manufacturing within Russia, possibly serving regulatory advantages and market segmentation.

  • Innovation Landscape:
    Continuous innovation in probiotic strain selection and fermentation technology can extend the patent life cycle and expand intellectual property portfolios in this domain.


FAQs

1. What is the primary inventive step in RU2711481?
The patent’s novelty lies in its specific combination of probiotic bacterial strains and precise fermentation conditions optimized for stability and viability in the Russian manufacturing context.

2. Can other probiotic strains be used without infringing RU2711481?
Yes. The patent claims are specific to certain strains and fermentation parameters, so alternative strains or different process conditions may avoid infringement if they do not fall within the scope of the claims.

3. How does RU2711481 compare to international probiotic patents?
It shares thematic similarities with international patents on probiotic formulations and production methods, but its specificity to strains and process parameters tailored for Russian regulations gives it a regional advantage.

4. Is the patent enforceable outside Russia?
No. RU2711481 is a Russian national patent; it is enforceable only within the Russian Federation unless corresponding patent rights are sought in other jurisdictions.

5. What is the potential for patent infringement disputes in this field?
Given overlapping probiotic production technologies worldwide, disputes may arise around fermentation processes and strains. Clear delineation of specific claims can mitigate risks, but companies should perform thorough freedom-to-operate analyses.


References

  1. Official Rospatent database. Patent RU2711481.
  2. European Patent Office (EPO). Patent EP2294997.
  3. United States Patent and Trademark Office (USPTO). Patent US8993300.
  4. Russian Patent RU2470904.
  5. Scientific literature on probiotic fermentation processes.

This comprehensive analysis aims to guide stakeholders in strategic decision-making, patent landscape navigation, and innovation planning surrounding RU2711481.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.